Centurium-led consortium completes $4.76b take-private deal of China Biologic

Centurium-led consortium completes $4.76b take-private deal of China Biologic

22 April, 2021

biopharmaceutical Centurium Capital China Biologic Citic Capital Hillhouse Capital NASDAQ Temasek Holdings

Printed by Unregistered user on Sun, 03 Aug 2025 09:32:06 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

China's Centurium Capital set to reach first close at $2b for latest PE fund

China Biologic draws investor flak over rejected takeover bid

Read more from Greater China

Venture Capital

Nuclear fusion startup NovaFusionX raises $70m angel round

Chinese robot maker AGIBot completes new round of financing